Shanghai Haohai Biological Technology Statistics
Total Valuation
Shanghai Haohai Biological Technology has a market cap or net worth of HKD 12.86 billion. The enterprise value is 10.77 billion.
Market Cap | 12.86B |
Enterprise Value | 10.77B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
Shanghai Haohai Biological Technology has 231.72 million shares outstanding. The number of shares has increased by 14.87% in one year.
Shares Outstanding | 231.72M |
Shares Change (YoY) | +14.87% |
Shares Change (QoQ) | -58.66% |
Owned by Insiders (%) | 63.10% |
Owned by Institutions (%) | 11.59% |
Float | 85.50M |
Valuation Ratios
The trailing PE ratio is 21.71 and the forward PE ratio is 12.92.
PE Ratio | 21.71 |
Forward PE | 12.92 |
PS Ratio | 3.53 |
PB Ratio | 1.20 |
P/FCF Ratio | 22.90 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.46, with an EV/FCF ratio of 33.90.
EV / Earnings | 22.47 |
EV / Sales | 3.65 |
EV / EBITDA | 16.46 |
EV / EBIT | 23.79 |
EV / FCF | 33.90 |
Financial Position
The company has a current ratio of 4.60, with a Debt / Equity ratio of 7.00.
Current Ratio | 4.60 |
Quick Ratio | 3.87 |
Debt / Equity | 7.00 |
Debt / EBITDA | 0.70 |
Debt / FCF | 1.43 |
Interest Coverage | 37.80 |
Financial Efficiency
Return on equity (ROE) is 6.94% and return on invested capital (ROIC) is 4.11%.
Return on Equity (ROE) | 6.94% |
Return on Assets (ROA) | 3.63% |
Return on Capital (ROIC) | 4.11% |
Revenue Per Employee | 1.35M |
Profits Per Employee | 220,013 |
Employee Count | 2,158 |
Asset Turnover | 0.38 |
Inventory Turnover | 1.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.03% in the last 52 weeks. The beta is 0.74, so Shanghai Haohai Biological Technology's price volatility has been lower than the market average.
Beta (5Y) | 0.74 |
52-Week Price Change | -8.03% |
50-Day Moving Average | 30.62 |
200-Day Moving Average | 29.01 |
Relative Strength Index (RSI) | 62.50 |
Average Volume (20 Days) | 120,556 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Haohai Biological Technology had revenue of HKD 2.95 billion and earned 479.41 million in profits. Earnings per share was 1.45.
Revenue | 2.95B |
Gross Profit | 2.05B |
Operating Income | 452.67M |
Pretax Income | 559.76M |
Net Income | 479.41M |
EBITDA | 631.69M |
EBIT | 452.67M |
Earnings Per Share (EPS) | 1.45 |
Balance Sheet
The company has 2.94 billion in cash and 455.78 million in debt, giving a net cash position of 2.49 billion or 10.73 per share.
Cash & Cash Equivalents | 2.94B |
Total Debt | 455.78M |
Net Cash | 2.49B |
Net Cash Per Share | 10.73 |
Equity (Book Value) | 6.51B |
Book Value Per Share | 26.23 |
Working Capital | 3.13B |
Cash Flow
In the last 12 months, operating cash flow was 729.55 million and capital expenditures -411.86 million, giving a free cash flow of 317.70 million.
Operating Cash Flow | 729.55M |
Capital Expenditures | -411.86M |
Free Cash Flow | 317.70M |
FCF Per Share | 1.37 |
Margins
Gross margin is 69.40%, with operating and profit margins of 15.34% and 16.25%.
Gross Margin | 69.40% |
Operating Margin | 15.34% |
Pretax Margin | 18.97% |
Profit Margin | 16.25% |
EBITDA Margin | 21.41% |
EBIT Margin | 15.34% |
FCF Margin | 10.77% |
Dividends & Yields
This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 2.80%.
Dividend Per Share | 0.88 |
Dividend Yield | 2.80% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 47.96% |
Buyback Yield | -14.87% |
Shareholder Yield | -12.07% |
Earnings Yield | 4.61% |
FCF Yield | 4.37% |
Stock Splits
The last stock split was on June 6, 2024. It was a forward split with a ratio of 1.4.
Last Split Date | Jun 6, 2024 |
Split Type | Forward |
Split Ratio | 1.4 |